Target intelligence / Profile preview

Endothelial tissue

Molecular classification
Other
01

Overview

Endothelial tissue is the specialized layer of cells lining the entire circulatory system, serving as a dynamic barrier and endocrine organ that regulates blood flow, vascular tone, and inflammatory cell recruitment (Sandoo et al., 2010, PMID: 21249170). At a defect site, such as a vascular injury or an atherosclerotic plaque, the endothelium becomes dysfunctional or denuded, triggering pathological processes like thrombosis and intimal hyperplasia (Gimbrone & García-Cardeña, 2016, PMID: 26876591). Therapeutic strategies often target this tissue to promote rapid healing and restore normal vascular function, utilizing growth factors or targeted delivery systems to localize treatment to the site of injury (Rajendran et al., 2013, PMID: 24251155). Because it is a tissue rather than a single molecule, it encompasses a wide array of potential molecular targets including receptors, adhesion molecules, and enzymes. Consequently, while it is a focus of clinical intervention, it does not represent a single canonical molecular target in the traditional pharmacological sense.

Other names
EndotheliumVascular endotheliumEndothelial layerVascular lining
02

Mechanism of action

Drugs targeting the endothelium at defect sites often utilize local delivery systems to inhibit smooth muscle cell proliferation (e.g., sirolimus), promote endothelial cell recovery (e.g., VEGF), or prevent thrombus formation by inhibiting platelet aggregation (e.g., aspirin) (Luscher et al., 2007, PMID: 17353431).

03

Biological functions

Cell proliferationImmune responseApoptosisOther
04

Disease associations

Cardiovascular diseaseInflammationOther
05

Safety considerations

Delayed re-endothelializationStent thrombosisSystemic toxicity from drug leachingHypersensitivity to polymer coatingsImpaired vascular healing
06

Interacting drugs

Paclitaxel

4 more in the full profile.

07

Biomarkers

Circulating endothelial cellsSoluble VCAM-1Soluble ICAM-1von Willebrand factorAsymmetric dimethylarginine

Beyond the preview

Go deeper on Endothelial tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endothelial tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call